EPA Orders Removal of Hospital Disinfectant From Market

The U.S. Environmental Protection Agency has issued a Stop Sale, Use, or Removal Order to stop the sale of ZEP Formula 165, a disinfectant manufactured by Zep in Atlanta, Ga., for use in hospitals.

Advertisement

Before selling or distributing any pesticide in the United States, companies must register pesticides with the EPA. Each producer, seller and distributor is required, under federal law, to ensure that the registered pesticide is labeled in accordance with EPA requirements.

 

Under the EPA’s antimicrobial testing program, ZEP Formula 165 was evaluated, and officials determined that contrary to labeling claims, the product was ineffective against Mycobacterium Tuberculosis.

Related Articles on Quality:

30 Statistics on Global Patient Satisfaction

Study Reveals Impact of CMS Payment Adjustment for HAIs

Study Reinforces Previous Research on Positive Impact of Technology on Hand Hygiene

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

  • In 2024, the Medicare Shared Savings Program had its strongest year on record. Even then, roughly one in four participating…

  • HCA Healthcare, a for-profit hospital operator based in Nashville, Tenn., is seeking leaders for numerous C-suite roles within the organization.…

Advertisement

Comments are closed.